Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Novartis Pharma
Woman and Man Max 99 years
Novartis Pharma Services AG
Update Il y a 5 ans
A 3 year study to determine if optical coherence tomography can be used to measure disease progression in patients with multiple sclerosis
To evaluate change in RNFL thickness in RRMS patients followed for up to 36 months compared to a group of reference subjects (without neurologic or ophthalmic disease) to determine whether the optical...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man
Between 18 years
and 99 years
Novartis Pharma
Update Il y a 5 ans
Étude CFGF401X2101 : étude de phase 1-2, en escalade de dose, évaluant la tolérance et l’efficacité d’un inhibiteur de FGFR , le FGF401, chez des patients ayant un carcinome hépatocellulaire ou une tumeur solide exprimant FGFR4 et KLB. [essai clos aux inclusions]
CFGF401X2101 Etude multicentrique de phase I/II en ouvert évaluant FGF401 administré par voie orale à des patients adultes atteints de carcinome hépatocellulaire ou de tumeurs solides exprimant FGFR4 ...
Country
France
organs
Primitif du foie
,
Tumeurs solides
Specialty
Thérapies Ciblées
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Novartis Pharma Services AG
Update Il y a 5 ans
A randomized, multi-center, parallel group, double blind, study to assess the safety of QMF Twisthaler® (500/400μg) and mometasone furoate Twisthaler® (400μg) in adolescent and adult patients with persistent asthma
• To compare the rate of serious asthma exacerbations resulting in hospitalization, intubation or death in patients treated with QMF 500/400 μg or MF 400 μg.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Pharma Services AG
Update Il y a 5 ans
Comparison of two ways of LCZ696 titration in heart failure patients
To assess the safety and tolerability of initiating LCZ696 in heart failure patients with reduced ejection fraction using conservative (reaching target dose over 6 weeks) and condensed (reaching targe...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Pharma Services AG
Update Il y a 5 ans
A randomized, double-blind, placebo-controlled, parallel group study to investigate the safety and tolerability of 14-days treatment with an inhaled dose of QMF149 (500/800) in mild to moderate asthmatic patients
To assess the safety and tolerability of 14 days of once a day, evening treatment with QMF149 (500/800 using the Twisthaler®) in patients with mild to moderate asthma, with the aim of identifying unex...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Pharma Services AG
Update Il y a 5 ans
Panobinostat with bortezomib and dexamethasone in relapsed or relapsed-and-refractory multiple myeloma
- To assess best overall response rate (ORR) up to 8 cycles
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Novartis Pharma B.V. (The Netherlands)
Update Il y a 5 ans
An open label randomised controlled study in elderly subjects with previously untreated acute myelogenous leukaemia, comparing treatment groups randomised to receive daunorubicin and cytarabine or daunorubicin, cytarabine and PSC-833
Not provided at time of registration
Country
Netherlands
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Pharma Services AG
Update Il y a 5 ans
Safety and tolerability of ACZ885 (Canakinumab) in patients with gout
The purpose of this third extension study is to provide additional long-term safety and tolerability data of canakinumab over an 18-month time period on patients who have completed the extension studi...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Pharma Services AG
Update Il y a 5 ans
A randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of oral RSV604 in healthy adults experimentally infected with respiratory syncytial virus
- To evaluate the antiviral activity of RSV604, given orally, on nasal RSV load, as measured by RT-PCR, in healthy adults experimentally inoculated with a challenge virus of RSV. - To evaluate the s...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Pharma Services AG
Update Il y a 5 ans
A phase III, randomized, double-blind, placebo-controlled multi-center study of ASA404 in combination with docetaxel in second-line treatment of patients with advanced or metastatic (stage IIIb/IV) non-small cell lung cancer (NSCLC)
To compare overall survival between the ASA404 plus docetaxel group and the placebo plus docetaxel group
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
13
14
15
16
17
18
19
20
21
22
Next